NCBI PubMed Central
open access
Cost-effectiveness analysis of a prognostic risk assessment for early-stage 1-3b diabetic kidney disease patients in the United States.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Omics‐Driven Machine Learning Path to Cost‐Effective Precision Medicine in Chronic Kidney Disease#11603
- Risk prediction models for malnutrition in dialysis patients in China: a systematic review and meta-analysis.#308818
- A Cost-Effectiveness Analysis Of Oropharyngeal Cancer Post-Treatment Surveillance Practices#167477
- Cost-effectiveness of PCI With Taxus vs CABG - 5 Years FUP#828330
- Economic Analysis of Alliance A041202 CLL Study#879933
Record · ID 671073
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive